Sign in
Cell BiologybioRxiv

Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors

K. Nishino, Y. Arai, K. Takasawa, M. Toyoda, M. Yamazaki-Inoue, T. Sugawara, H. Akutsu, K. Nishimura, M. Ohtaka, M. Nakanishi, A. Umezawa

Abstract

Human induced pluripotent stem cells (iPSCs) are established by introducing several reprogramming factors, such as OCT3/4, SOX2, KLF4, c-MYC. Because of their pluripotency and immortality, iPSCs are considered to be a powerful tool for regenerative medicine. To date, iPSCs have been established all over the world by various gene delivery methods. All methods induced high-quality iPSCs, but epigenetic analysis of abnormalities derived from differences in the gene delivery methods has not yet been performed. Here, we generated genetically matched human iPSCs from menstrual blood cells by using three kinds of vectors, i.e., retrovirus, Sendai virus, and episomal vectors, and compared genome-wide DNA methylation profiles among them. Although comparison of aberrant methylation revealed that iPSCs generated by Sendai virus vector have lowest number of aberrant methylation sites among the three vectors, the iPSCs generated by non-integrating methods did not show vector-specific aberrant methylation. However, the differences between the iPSC lines were determined to be the number of random aberrant hyper-methylated regions compared with embryonic stem cells. These random aberrant hyper-methylations might be a cause of the differences in the properties of each of the iPSC lines.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISVashistha '26Angeles '24Grigor’eva '18Kagan '16Panther '21Roychowdhur '26
68% semantic matchCell Biology
Saksham Vashistha, Sarrianna Hoffer, Jessica Dade+5 more·Molecular Therapy Advances·Mar 20, 2026· 1 citations